Cartesian Therapeutics, Inc. (RNAC) › Total LiabilitiesCartesian Therapeutics, Inc. (RNAC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $21.84M2016: $34.34M2018: $49.90M2019: $91.17M2020: $183.44M2021: $137.36M2022: $72.06M2023: $444.68M2024: $441.82M2025: $422.65M$422.65M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$422.65M-4.3%2024$441.82M-0.6%2023$444.68M+517.1%2022$72.06M-47.5%2021$137.36M-25.1%2020$183.44M+101.2%2019$91.17M+82.7%2018$49.90M—2016$34.34M+57.3%2015$21.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share